Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

Similar documents
Medication-Assisted Treatment. What Is It and Why Do We Use It?

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

Treatment Alternatives for Substance Use Disorders

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

AMBULATORY DETOXIFICATION In the 21 st Century

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Methadone and Naltrexone ER

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP

Treating Opioid Addiction

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

Buprenorphine as a Treatment Option for Opioid Use Disorder

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Medication Assisted Treatment

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Opiate Use Disorder and Opiate Overdose

MAT in the Corrections Setting

THE STATE OF MEDICINE IN ADDICTION RECOVERY

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

2/21/2018. What are Opioids?

Closing the Loop in Treating Opioid Addiction:

Medicaid and the Opioid Crisis

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

The Social Worker s Role in Medication Assisted Treatment

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

Medication Supported Recovery- A Review of Evidence-Based Practice

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

Aetna s Initiative on the Opioid Epidemic

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement

7/7/2016 Journal of the American Medical Association,

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

Fighting Today s Opioid Epidemic

Vivitrol Drug Court and Medication Assisted Treatment

Opioid Use Disorder Treatment Initiation in Diverse Settings

SW OREGON OPIOID SUMMIT. Medication Assisted Recovery for Opioid Use Disorder. Gregory S. Brigham, Ph.D. Adapt / SouthRiver CHC / Compass

NALTREXONE DAVID CRABTREE, MD, MPH UNIVERSITY OF UTAH HEALTH, 2018

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP

Opioid Use Disorders &Medication Treatment

Earl Hightower's Remarks 2014 National Rx Drug Abuse Summit Medication Assisted Treatment for Opiate Addiction

HARM REDUCTION & TREATMENT. Devin Reaves MSW

Child Welfare and MOMS: Building Partnerships to Improve Care

Understanding and Combating the Heroin Epidemic

Medication-Assisted Treatment (MAT) Overview

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

Helping Recovery Residences Adapt

ROSC & MAT II: Opioid Treatment Services

MEDICATION Assisted Treatment

Building capacity for a CHC response to Ontario's Opioid Crisis

Medication-Assisted Treatment (MAT) for Opioid Use Disorders

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

Substance Use Disorder Response

Recovery U: Medication Assisted Treatment (MAT)

Topics of today s training

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Serious Mental Illness and Opioid Use Disorder

Successful discharges from opiate substitution therapy dose reduction to zero

Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus

Identification and Treatment of Opioid Use Disorders in Primary Care Settings

AGENDA U.S. SURGEON GENERAL, VIVEK MURTHY MD 2/5/2019

U.S. SURGEON GENERAL, VIVEK MURTHY MD

EFFECTIVE AND RESPONSIBLE MEDICATION ASSISTED TREATMENT

FIGHTING THE OPIOID EPIDEMIC- ONE PRACTICE CAN MAKE A DIFFERENCE IN YOUR COMMUNITY.

Pregnancy, MAT and Addiction

Methadone Maintenance 101

Management Options for Opioid Dependence:

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

MEDICATION ASSISTED TREATMENTS (MAT) FOR SUBSTANCE USE DISORDERS

DRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS

GOALS AND OBJECTIVES

6/6/2018. Objectives. Outline. Rethinking Medication Treatment for Opioid Use Disorder

Exploring Barriers & Solutions in Facilitating Detox

Methadone and Naltrexone ER

Family Health Centers of San Diego Alcohol and Other Drug Services

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Treatment of Opioid Use Disorder

Treatment of Opioid Use Disorder

8/14/2017. Practical Approach to Office Based Addiction Treatment. Objectives. Foundation For Success Treating SUD

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Medication Assisted Treatment. Nicole Gastala, MD

Evidence-Based Practices for the Treatment of Opioid Use Disorder. Zach Ludwig, LPC Corporate Director Clinical Programs Bradford Health Services

AODA RECOVERY. How to support those in recovery, and those not yet ready to commit

Opioids Research to Practice

Suboxone Addiction & Treatment

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

Supporting Sustained Recovery for Opioid Use Disorder

LESSONS FROM THE PHYSICIAN HEALTH PROGRAM (PHP) EXPERIENCE FOR TODAY'S NATIONAL OPIOID EPIDEMIC

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

The Role of Urgent Care in responding to the opioid Crisis

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont

1) To understand the scope of the opioid epidemic with relation to Emergency Departments 2) To gain insight into some emerging Emergency Medicine

Prescription Opioid Addiction

Ken Roy, MD, FASAM. The Opioid Epidemic and Addiction Involving the Use of Opioids. Tulane & LSU Department of Psychiatry

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Medication for the Treatment of Addiction (MAT)

Latest Research on Addiction and Treatment

Transcription:

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction Medicine

Historically Treatment options were limited with little long term follow up. - Typical Inpatient Detox and rehab in a 28 day program -Comfort medications or agonist taper; typically with methadone - 12 step programs for follow up after rehab (AA/NA) - Federally regulated methadone clinics in communities. - effective but controversial

Objectives Identify the medications used in medication assisted treatment. Understand the role of medication assisted treatment in recovery. Have a better understanding of how to present MAT to your patients or refer them for treatment/mat.

Medication Assisted Treatment (MAT) MAT is treatment for opioid addiction that includes the use of medication along with counseling and other support. The most common medications used in MAT are : 1. Methadone 2. Buprenorphine 3. Naltrexone

Medication Assisted Treatment What medications can be used for treatment of Opioid Use Disorders in the United States?? DATA 2000 Methadone by prescription (pain only) DEA CII Naltrexone by prescription

Partial Agonist /Antagonist Medications Buprenorphine (Suboxone) DATA 2000 DEA X number Limited prescribers by design Waived Physician (??) Limits 30,100, 275 (recent) Is a CIII substance and further regulated some states. Naltrexone (Vivitrol) Initially approved for Alcohol dependence then Opioid Dependence NOT a controlled Substance No limited prescribers No additional training

The Future Detoxification for opiates unless paired with a long acting antagonist (Vivitrol, Naltrexone Implant), longitudinal monitoring and CM will not be seen as medically appropriate Treating depression and other co-occurring disorders will become more important The use of agonists for opiate dependency will be seen through a medical lens rather than a spiritual lens Agonist therapy by itself will never suffice low retention, high cooccurring substance misuse

What Doesn t Work? Detox by itself No better than no treatment Medications for cocaine, stimulants Oral naltrexone for opiate dependency OD risk SBIRT (Screening, Brief Intervention, Referral to Treatment) You must do more

Drug Treatments: What Works? Standard treatment counseling and community support Longer treatment is always better than shorter treatment but the setting may be less important UDS Monitoring + rewards/consequences improves outcomes across a range of drug dependencies No single medication treatment works better than 40% of the time at 1 year Reduced use is more common and stable than abstinence in the first year following treatment

Ensuring Opiate Clients Get Medications

Opioid Use Disorder -addiction is a brain disorder its symptoms may be drugs, alcohol, gambling, sex.. -long term treatment is needed as in traditional medical disease states Diabetes model/cvd -Return to functioning and treatments may change with time. -Medication alone is never the answer -Treat co-occurring MH diagnoses MDD, BP, Mood DO, ADD,PTSD -Treat co-occurring Medical diagnoses DM2,HTN,CAD,MS,DJD Abstinence Opioid Use Disorder MAT

Treatment Concerns Inpatient treatment is becoming increasingly difficult even with tools such as ASAMs PPC. Every benefits plan is different. Be prepared for quick discharges and transfers to lower levels of care. Include the patient in the treatment plan so they are not surprised. We can no longer NOT discuss treatment options with our patients. Informed consent is expected. Change happens slowly and is often bidirectional. Treatments will change over time. Fostering those changes is our responsibility as providers

Questions? Thoughts? MAT is not drug substitution MAT is not effective without a complete treatment plan Detox only is not treatment Not one treatment works for everyone Cravings are real and relapse is real AEDs save lives. Narcan saves lives too